BioCryst Pharmaceuticals Inc logo

BioCryst Pharmaceuticals Inc

NEW
NAS:BCRX (USA)   Ordinary Shares
$ 9.38 +0.070 (+0.75%) 10:08 PM EST
At Loss
Market Cap:
$ 2.40B
Enterprise V:
$ 2.84B
Volume:
4.38M
Avg Vol (2M):
4.89M
Trade In:
Volume:
4.38M
At Loss
Avg Vol (2M):
4.89M

BCRX Stock Institutional Ownership and Insider Ownership - BioCryst Pharmaceuticals Inc

255.54
(Mil)
Shares Outstanding
97.87%
248.75 (Mil)
Institutional Ownership
3.33%
8.45 (Mil)
Insider Ownership
99.25%
253.6341 (Mil)
Float Percentage of TSO

Short Interest History (%)

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

Institutional Ownership History (%)

This the Institutional Ownership History of BioCryst Pharmaceuticals Inc. Peter Lynch prefers to buy companies with low institutional ownership.
* Due to varying ownership data coverage and corporate events such as splits, the information in this section is in no way guaranteed for completeness, accuracy or in any other way.

Insider ownership (%)

This is the historical insider ownership of BioCryst Pharmaceuticals Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.
1. Please note that our data vendor collects insider data for officers and directors from Forms 3,4,5 and amendments where they only capture direct ownership data, not indirect ownership.
* Due to varying ownership data coverage and corporate events such as splits, the information in this section is in no way guaranteed for completeness, accuracy or in any other way.

Top Direct Holders

Top Fund Holders